Mammary growth hormone and tumorigenesis--lessons from the dog.
The discovery in the early 1990s that progestin-induced growth hormone (GH) excess in the dog originates in the mammary gland can be seen as a hallmark in the research on the pathogenesis of mammary cancer in the dog. The local biosynthesis and release of GH may provide a highly proliferative environment in the mammary gland, which contributes to the development and/or progression of mammary tumours. Before final goals such as prevention of tumour formation or inhibition of tumour promotion can be achieved it is of eminent importance to elucidate the mechanism of progesterone-induced mammary GH production and the mechanism of local autocrine/paracrine action of GH. These local GH effects may be achieved through direct growth stimulating effects of GH as well as by indirect effects mediated by the stimulation of the biosynthesis of insulin-like growth factor-I (IGF-I). The biological effects of the IGFs largely depend on the presence of IGF binding proteins (IGFBPs) which may both enhance or inhibit the activity of the IGFs. This review concentrates on recent advances in the understanding of the local mammary GH-IGF axis and the lessons which can be drawn from the dog for mammary cancer research in other species.
Mol
J A
JA
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. j.mol@vet.uu.nl
Lantinga-van Leeuwen
I S
IS
van Garderen
E
E
Selman
P J
PJ
Oosterlaken-Dijksterhuis
M A
MA
Schalken
J A
JA
Rijnberk
A
A
D000818:Animals; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004285:Dogs; D005260:Female; D013006:Growth Hormone / Q000096:biosynthesis*; D008321:Mammary Glands, Animal / Q000166:cytology / Q000473:pathology / Q000502:physiology*; D015674:Mammary Neoplasms, Animal / Q000473:pathology / Q000503:physiopathology*; D011986:Receptors, Somatotropin / Q000502:physiology
D011986:Receptors, Somatotropin; D013006:Growth Hormone